3gi5
From Proteopedia
(Difference between revisions)
												
			
			| Line 1: | Line 1: | ||
{{Seed}}  | {{Seed}}  | ||
| - | [[Image:3gi5.  | + | [[Image:3gi5.png|left|200px]]  | 
<!--  | <!--  | ||
| Line 12: | Line 12: | ||
===Crystal structure of protease inhibitor, KB62 in complex with wild type HIV-1 protease===  | ===Crystal structure of protease inhibitor, KB62 in complex with wild type HIV-1 protease===  | ||
| + | |||
| + | <!--   | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_20237088}}, adds the Publication Abstract to the page   | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 20237088 is the PubMed ID number.  | ||
| + | -->  | ||
| + | {{ABSTRACT_PUBMED_20237088}}  | ||
==About this Structure==  | ==About this Structure==  | ||
3GI5 is a 2 chains structure with sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3GI5 OCA].   | 3GI5 is a 2 chains structure with sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3GI5 OCA].   | ||
| + | |||
| + | ==Reference==  | ||
| + | <ref group="xtra">PMID:20237088</ref><references group="xtra"/>  | ||
[[Category: Human immunodeficiency virus 1]]  | [[Category: Human immunodeficiency virus 1]]  | ||
[[Category: Nalam, M N.L.]]  | [[Category: Nalam, M N.L.]]  | ||
| Line 26: | Line 35: | ||
[[Category: Protease inhibitor]]  | [[Category: Protease inhibitor]]  | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed   | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed May 26 08:39:15 2010''  | 
Revision as of 04:35, 26 May 2010
Crystal structure of protease inhibitor, KB62 in complex with wild type HIV-1 protease
Template:ABSTRACT PUBMED 20237088
About this Structure
3GI5 is a 2 chains structure with sequences from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
Reference
- Nalam MN, Ali A, Altman MD, Reddy GS, Chellappan S, Kairys V, Ozen A, Cao H, Gilson MK, Tidor B, Rana TM, Schiffer CA. Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance. J Virol. 2010 May;84(10):5368-78. Epub 2010 Mar 17. PMID:20237088 doi:10.1128/JVI.02531-09
 
Page seeded by OCA on Wed May 26 08:39:15 2010
